Cancer Numbers in Italy AIOM

As liquid biopsy technology improves, cancer research stands to benefit

FDA announces a re-classification of most high-risk IVDs, including companion diagnostics

Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay

EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients